The goal of Doloromics is to find better ways to treat chronic pain
To achieve this goal, we have two main approaches, both of which use cutting edge computational techniques to analyze genomic sequencing data from human patients:
1. Analyze existing datasets using our proprietary algorithms to identify novel drug-targets
2. Identify biomarkers in chronic pain patients to help identify individualized treatment options
To achieve this goal, we have two main approaches, both of which use cutting edge computational techniques to analyze genomic sequencing data from human patients:
1. Analyze existing datasets using our proprietary algorithms to identify novel drug-targets
2. Identify biomarkers in chronic pain patients to help identify individualized treatment options
Location: United States, California, Menlo Park
Employees: 1-10
Founded date: 2020
Investors 2
| Date | Name | Website |
| 18.09.2022 | Future Ven... | future.ven... |
| - | First In V... | firstinven... |
Mentions in press and media 1
| Date | Title | Description |
| - | Check out the life science startups taking part in the pitch contest at INVEST Precision Medicine | Neurostimulation to treat memory loss, improving clinical outcomes for women’s health, identifying novel drug targets for chronic pain, wireless drug delivery, and opioid risk prediction. These are among the areas of interest for companies ... |